Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Other Operating Expenses (2016 - 2025)

Apyx Medical (APYX) has disclosed Other Operating Expenses for 11 consecutive years, with $16000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 109.82% year-over-year to $16000.0, compared with a TTM value of $13.9 million through Dec 2025, up 8740.37%, and an annual FY2025 reading of $92000.0, up 157.14% over the prior year.
  • Other Operating Expenses was $16000.0 for Q4 2025 at Apyx Medical, down from $4.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $4.7 million in Q2 2025 and bottomed at -$192000.0 in Q3 2021.
  • Average Other Operating Expenses over 5 years is $793157.9, with a median of -$1000.0 recorded in 2024.
  • The sharpest move saw Other Operating Expenses tumbled 320.0% in 2024, then skyrocketed 469400.0% in 2025.
  • Year by year, Other Operating Expenses stood at -$185000.0 in 2021, then soared by 375.14% to $509000.0 in 2022, then plummeted by 101.57% to -$8000.0 in 2023, then tumbled by 1937.5% to -$163000.0 in 2024, then skyrocketed by 109.82% to $16000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for APYX at $16000.0 in Q4 2025, $4.7 million in Q3 2025, and $4.7 million in Q2 2025.